Search alternatives:
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
small decrease » small increased (Expand Search)
point decrease » point increase (Expand Search)
significant linear » significant clinical (Expand Search), significant gender (Expand Search), significant level (Expand Search)
linear decrease » linear increase (Expand Search)
small decrease » small increased (Expand Search)
point decrease » point increase (Expand Search)
-
201
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
202
-
203
-
204
-
205
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
206
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
207
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
208
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
209
-
210
-
211
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
212
-
213
-
214
-
215
-
216
-
217
HFD decreases intermediate-term memory.
Published 2025“…<p>(A) The survival rate of 10d <i>Canton-S</i> fed with ND or HFD was observed for 7 days. There was no significant decline in the survival rate in flies fed with HFD compared with ND (n = 10 vials, containing 20 flies at each time point). …”
-
218
-
219
-
220